N1-(4-Butyl-2-methylphenyl)acetamide

N1-(4-Butyl-2-methylphenyl)acetamide Suppliers list
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: LETOPHARM LIMITED  
Tel: +86-21-5821 5861
Email: sales@letopharm.com
Company Name: SPIRO PHARMA  
Tel:
Email: eric_feng1954@126.com
Company Name: Guangzhou QiYun Biotechnology Co., Ltd.  
Tel: 020-61288194 61288195
Email: 505721671@qq.com
Company Name: Chengdu Huachun Technology Co., Ltd  
Tel: 400-1166-196 15982826727
Email: cdhxsj@163.com
N1-(4-Butyl-2-methylphenyl)acetamide Basic information
Product Name:N1-(4-Butyl-2-methylphenyl)acetamide
Synonyms:4-N-BUTYL-2-METHYLACETANILIDE;SMIP 004;SMIP004;SMIP-004;4'-(But-1-yl)-2'-methylacetanilide;N-[4-(But-1-yl)-2-methylphenyl]acetamide, 2-Acetamido-5-(but-1-yl)toluene;N-(4-Butyl-2-methylphenyl)acetamide;SMIP 004; SMIP-004
CAS:143360-00-3
MF:C13H19NO
MW:205.3
EINECS:
Product Categories:
Mol File:143360-00-3.mol
N1-(4-Butyl-2-methylphenyl)acetamide Structure
N1-(4-Butyl-2-methylphenyl)acetamide Chemical Properties
Boiling point 343.0±21.0 °C(Predicted)
density 1.003±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility ≥ 20.5 mg/mL in DMSO, ≥ 53.6 mg/mL in EtOH with ultrasonic
pka15.14±0.70(Predicted)
form Solid
color White to off-white
InChI1S/C13H19NO/c1-4-5-6-12-7-8-13(10(2)9-12)14-11(3)15/h7-9H,4-6H2,1-3H3,(H,14,15)
InChIKeyZFVMECVBUGMWIX-UHFFFAOYSA-N
SMILESN(c1c(cc(cc1)CCCC)C)C(=O)C
Safety Information
WGK Germany WGK 2
HS Code 2924297099
Storage Class11 - Combustible Solids
MSDS Information
N1-(4-Butyl-2-methylphenyl)acetamide Usage And Synthesis
UsesSMIP004 is a SKP2 E3 ligase inhibitor, which downregulates SKP2 and to stabilise p27. SMIP004 is a cancer cell selective apoptosis inducer of human prostate cancer cells[1][2].
Biological ActivityCell permeable: yes', 'Reversible: yes
in vivo

SMIP004 potently inhibits the growth of prostate and breast cancer xenografts in SCID mice[2].

storageStore at -20°C
References[1] Li C, et al. SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination. J Exp Clin Cancer Res. 2019 Feb 13;38(1):76. DOI:10.1186/s13046-019-1069-3
[2] Rico-Bautista E, Zhu W, Kitada S, Small Molecule-Induced Mitochondrial Disruption Directs Prostate Cancer Inhibition via UPR Signaling. Oncotarget. 2013 Jul 14. DOI:10.18632/oncotarget.1130
N1-(4-Butyl-2-methylphenyl)acetamide Preparation Products And Raw materials
Tag:N1-(4-Butyl-2-methylphenyl)acetamide(143360-00-3) Related Product Information
N1-(4-Butyl-2-methylphenyl)acetamide Oxalinast AKOS BBS-00005354 2(1H)-Quinolinone, 6-(4-(4-phenyl-1-piperazinyl)butyl)- AKOS 90787 2(1H)-Quinolinone, 3,4-dihydro-6-(4-(4-(2-chlorophenyl)-1-piperazinyl) butyl)- AKOS 90786 AKOS 226-01 AURORA KA-6681 AKOS 226-09 AKOS 90612 AKOS 90610 AKOS 226-12 AKOS 226-22 3,4-Diazabicyclo(4.1.0)hept-4-en-2-one, 5-(2,3,4,5-tetrahydro-2-oxo-1H -1-benzazepin-7-yl)- N1-(4-Butyl-2-methylphenyl)-2-chloroacetamide 2-Chloro-N-(2-tert-butyl-6-methylphenyl)acetamide N1-(5-([2-(4-Butyl-2-methylanilino)-2-oxoethyl]thio)-1,3,4-thiadiazol-2-yl)-4-chloro-3-nitrobenzamide